Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02207530
Title Phase II Study of MEDI4736 Monotherapy in the Treatment of Patients With Recurrent or Metastatic SCCHN.
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca

head and neck squamous cell carcinoma



Age Groups: adult
Covered Countries USA | CAN

No variant requirements are available.